From the passage of the Affordable Care Act (ACA) in 2010 to the disruptions of a once-in-a-century pandemic, the past decade has seen rapid evolution in the US health care system. Behind the partisan political controversy, where does US health care stand today? What’s working in the system and what isn’t? And are we any closer to a sustainable approach that can both lower costs and improve outcomes?
In this episode, The Conference Board CEO Steve Odland hosts a wide-ranging conversation Steve Messinger, partner at ECG Management Consultants and recognized leader in health care consulting. Tune in to explore:
Join experts from The Conference Board as they share Trusted Insights for What’s Ahead®
C-Suite Perspectives is a series hosted by our President & CEO, Steve Odland. This weekly conversation takes an objective, data-driven look at a range of business topics aimed at executives. Listeners will come away with what The Conference Board does best: Trusted Insights for What’s Ahead®.
C-Suite Perspectives provides unique insights for C-Suite executives on timely topics that matter most to businesses as selected by The Conference Board. If you would like to suggest a guest for the podcast series, please email csuite.perspectives@conference-board.org. Note: As a non-profit organization under 501(c)(3) of the IRS Code, The Conference Board cannot promote or offer marketing opportunities to for-profit entities.
C-Suite Perspectives / 04 Aug 2025
More C-Suite leaders view their boards as effective in 2025, but numerous challenges remain, including keeping up with AI.
C-Suite Perspectives / 29 Jul 2025
We break down the latest data from The Conference Board Consumer Confidence Index®, released today.
C-Suite Perspectives / 28 Jul 2025
Learn how Clorox invested in technological innovation so it could continue delivering superior consumer experiences.
C-Suite Perspectives / 21 Jul 2025
2025 is half over. What issues should human capital leaders focus on during the rest of the year?
C-Suite Perspectives / 14 Jul 2025
Learn why culture and constant innovation are essential to developing life-changing biopharma treatments.
C-Suite Perspectives / 07 Jul 2025
We've just passed the midway point of 2025 -- what are the top 10 priorities for chief marketing officers (CMOs) for the rest of the year?